50 Shades of Subconjunctival MIGS: Interventional Glaucoma, The Who, What, Why, and How | ASCRS
CME Activity
50 Shades of Subconjunctival MIGS: Interventional Glaucoma, The Who, What, Why, and How
September 2019

CME Activity Details

Activity Availability

This CME activity is available to all ophthalmologists. Click the button below to access this activity in the CME 24/7 portal. 

Begin Activity Now

Description

Enjoy this 60-minute CME activity in which a panel of experts discuss subconjuctival MIGS. Topics include interventional glaucoma for the subconjuctival MIGS patient, a patient selection case study debate and discussion, and MIGS from the cataract surgeon perspective.

CME Information

This activity is supported by educational grants from Allergan and Santen Pharmaceuticals.
Credits
: By completing this activity you will earn 1.0 AMA PRA Category 1 Credits™.
Activity Expiration Date: August 31, 2020

Learning Objectives

Upon successful completion of this activity, participants should be able to:

  • Determine how best to apply therapeutic options and treatment decisions in cases of advanced or refractory glaucoma
  • Identify patient selection criteria and intra- and postoperative steps necessary to optimize outcomes with subconjunctival MIGS

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.